CERVICAL CANCER VACCINE READY TO USE FOR THE HEALTH CARE SYSTEM AS PER THE CEO (SERUM INSTITUTE OF INDIA) .

CERVICAL CANCER VACCINE READY TO BE PRICED RUPEES 200 TO 400:--  India's first indigenously developed quadrivalent human papilloma virus (HPV) vaccine for the prevention of the cervical cancer will be launched with in few months and made available to the people of country in an affordable price range between rupees two hundred to four hundred.Serum institute of India CEO Adar poonawala said on Tuesday on the issue and matter developed by the  Serum Institute of India.Speaking on the event held to announce the scientific research on the captioned subject matter deliberation required to be noticed on the time required for its completion.The  union minister of science and technology Shri Jitender Singh said the vaccine will be affordable and the government will ensure that it is accessible to the common man. Scientific completion implies that R&D Activities pertaining to the said vaccine are almost complete and now the next step of making them available to the public would take place for the use of said vaccine in the field of necessary observation by the health care services. The Schemes like Ayushmann Bharat have made us to think about the preventive health care system and demand under public utilities and now we can easily afford it .The Department of the Biotechnology has taken a lead in the subject matter deliberation required to be accomplished as soon as possible and are in the collaborative mode ,so it will be available for the preventive measures and use for the cervical cancer.